Quantcast
Last updated on April 17, 2014 at 9:59 EDT

Latest ALK-Abelló Stories

2012-08-29 10:23:25

ROUND ROCK, Texas, Aug. 29, 2012 /PRNewswire/ -- ALK is pleased to announce that it has signed an agreement with HealthTrust Purchasing Group, LP to supply PRE-PEN® (benzylpenicilloyl polylysine injection USP) the only FDA approved skin test for the diagnosis of penicillin allergy, to HealthTrust member facilities, including 1,400 acute care facilities, 10,600 ambulatory surgery centers, physician practices and alternate care sites. HealthTrust will incorporate PRE-PEN®...

2012-07-12 02:27:16

ROUND ROCK, Texas, July 12, 2012 /PRNewswire/ -- The FDA Safety Innovation Act (FDASIA), signed yesterday, provides pharmaceutical manufacturers with an extended window of antibiotic formulary exclusivity. This incentive should increase drug innovation, but it doesn't address increasing antimicrobial drug resistance, according to noted expert, Dr. David Khan of The University of Texas Southwestern Medical Center in Dallas. "Too often, a patient's self-reported penicillin allergy causes...

2011-10-17 09:00:00

ALK-Abelló is pleased to announce the marketing authorization of PRE-PEN® by Health Canada. PRE-PEN®, a penicillin skin test reagent, received Health Canada approval on September 21, 2011. Round Rock, TX (PRWEB) October 17, 2011 ALK-Abelló is pleased to announce the marketing authorization of PRE-PEN® by Health Canada. PRE-PEN®, a penicillin skin test reagent, received Health Canada approval on September 21, 2011. PRE-PEN® was a widely used skin test...